US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 20.715
  • -0.025-0.12%
Trading Mar 19 14:13 ET
665.47MMarket Cap-8.12P/E (TTM)

About Dianthus Therapeutics Company

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.

Company Profile

SymbolDNTH
Company NameDianthus Therapeutics
Listing DateJun 21, 2018
Founded2015
CEOMr. Marino Garcia
MarketNASDAQ
Employees78
Fiscal Year Ends12-31
Address7 Times Square,43rd Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-929-999-4055
Websitehttp://dianthustx.com

Company Executives

  • Name
  • Position
  • Salary
  • Marino Garcia
  • President, Chief Executive Officer and Director
  • --
  • Dr. Simrat Randhawa, M.D.
  • Chief Medical Officer
  • --
  • Edward G. Carr
  • Chief Accounting Officer
  • --
  • Ryan Savitz
  • Chief Financial Officer, Chief Business Officer and Treasurer
  • --
  • Adam M. Veness
  • Senior Vice President, General Counsel and Secretary
  • --
  • Alison F. Lawton
  • Chairman of the Board
  • --
  • Sujay R. Kango
  • Director
  • --
  • Dr. Steven Joseph Romano, M.D.
  • Director
  • --
  • Dr. Jonathan Violin, M.B.A.,PhD
  • Director
  • --
  • Leon O. Moulder, Jr
  • Director
  • --
  • Paula Soteropoulos
  • Independent Director
  • --
  • Anne M. McGeorge
  • Independent Director
  • --
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Hutchmed (China)
HCM
+8.96%
New Fortress Energy
NFE
+3.65%
DexCom
DXCM
+3.20%
eBay
EBAY
+2.62%
Halozyme Therapeutics
HALO
+1.68%

Unlock the Full List